Taysha Gene Therapies
TSHA
#6866
Rank
โ‚ฌ0.42 B
Marketcap
2,08ย โ‚ฌ
Share price
8.46%
Change (1 day)
30.62%
Change (1 year)

Taysha Gene Therapies (TSHA) Fails to deliver data

Key failure to deliver metrics for Taysha Gene Therapies:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Taysha Gene Therapies (TSHA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Taysha Gene Therapies (TSHA) - since 2020

Volume in USD (price x number of shares), data since 2020

Taysha Gene Therapies (TSHA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚ฌ3.97 M-18.1%
2023โ‚ฌ4.85 M-68.08%
2022โ‚ฌ15.2 M346.84%
2021โ‚ฌ3.4 M-30.11%
2020โ‚ฌ4.86 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚ฌ1.5 Mโ‚ฌ5.99 M๐Ÿ‡บ๐Ÿ‡ธ USA